Table 1 Cell products from all participants passed all requirements outlined by Health Canada to allow for injection into humans upon clinical trial approval.
Participant 1 | Participant 2 | Participant 3 | Participant 4 | Participant 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Unlabeled | Labeled | Labeled | Unlabeled | Labeled | Unlabeled | Labeled | Unlabeled | Labeled | ||
Stat Gram Stain | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass |
Endotoxin | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass |
CD45+ | 99.3% | 99.7% | 84.4% | 92.5% | 78.9% | 96.0% | 94.7% | 97.1% | 98.4% | 98.2% |
14-day Sterility | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass |
Mycoplasma | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass | Pass |
